Abiopharma

🔍 Wood Larry L (Director)

Company: PROCEPT BioRobotics Corp (PRCT)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Acquired 182,392 shares of Common Stock (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 185,595.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 319,618 shares of Stock Option (Right to Buy) at $39.57 per share (Derivative)
  Date: 2025-09-02 | Code: A | Expires: 2036-09-01 | equity_swap_involved: 0 | shares_owned_after: 319,618.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on September 2, 2026, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.
• F2: The ending balance was adjusted to reflect the forfeiture (for no consideration) of 2,765 unvested RSUs previously granted to the Reporting Person in April 2024 and June 2025 under the issuer's non-employee director compensation program.
• F3: The Stock Option was granted on September 2, 2025 and one-quarter of the shares subject to the Stock Option will vest on September 2, 2026, and the remainder shall vest monthly thereafter at the rate of 1/48th of the original number of shares subject to the Stock Option, subject to the Reporting Person continuing as a service provider through such date.